0001209191-19-014938.txt : 20190301
0001209191-19-014938.hdr.sgml : 20190301
20190301160829
ACCESSION NUMBER: 0001209191-19-014938
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20190301
DATE AS OF CHANGE: 20190301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARCUS JOEL S
CENTRAL INDEX KEY: 0001216955
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 19649362
MAIL ADDRESS:
STREET 1: C/O ALEXANDRIA REAL ESTATE EQUITIES, INC
STREET 2: 385 E. COLORADO BLVD. SUITE 299
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2018-06-14
2018-06-18
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001216955
MARCUS JOEL S
C/O ALEXANDRIA REAL ESTATE EQUITIES, INC
385 EAST COLORADO BOULEVARD, SUITE 299
PASADENA
CA
91101
1
0
0
0
Common Stock
2018-06-14
4
A
0
1500
0.00
A
8500
D
Common Stock
4000
I
Held by the Joel S. Marcus and Barbara A. Marcus Family Trust
Common Stock
908355
I
See footnote
Non-Qualified Stock Option (Right to Buy)
45.65
2018-06-14
4
A
0
5000
0.00
A
2025-06-13
Common Stock
5000
5000
D
These restricted stock units shall vest on June 14, 2019, subject to the Reporting Person's continuous service.
Consists of shares of common stock held by Alexandria Equities, LLC. Mr. Marcus is the Chairman, CEO and Founder of Alexandria Real Estate Equities, Inc., which is the managing member of Alexandria Equities, LLC, which has full voting and investment power with respect to the shares owned by Alexandria Equities, LLC. As an officer of Alexandria Real Estate Equities, Inc., Mr. Marcus may be deemed to have voting and investment power with respect to the shares owned by Alexandria Equities, LLC. Mr. Marcus disclaims beneficial ownership of the shares held by Alexandria Equities, LLC, except to the extent of his underlying pecuniary interest therein.
The option shall vest on June 14, 2019, subject to the Reporting Person's continuous service.
This amendment is being filed solely to attach the Power of Attorney that was inadvertently omitted at the time of filing.
/s/ David Tucker, Attorney-in-Fact
2019-03-01
EX-24.4A_837950
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned, as a Section 16 reporting person of Atara
Biotherapeutics, Inc. (the "Company"), hereby constitutes and appoints John
McGrath, David Tucker, Nimit Arora, Heather Turner, and Kim Merritt the
undersigned's true and lawful attorneys-in-fact to:
1. Complete and execute Forms 3, 4 and 5 and other forms and all
amendments thereto as such attorneys-in-fact shall in their discretion determine
to be required or advisable pursuant to Section 16 of the Securities Exchange
Act of 1934 (as amended) and the rules and regulations promulgated thereunder,
or any successor laws and regulations, as a consequence of the undersigned's
ownership, acquisition or disposition of securities of the Company; and
2. Do all acts necessary in order to file such forms with the
Securities and Exchange Commission, any securities exchange or national
association, the Company and such other person or agency as the
attorneys-in-fact shall deem appropriate.
The undersigned hereby ratifies and confirms all that said
attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, is not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934 (as amended).
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.
The undersigned hereby terminates all prior powers of attorney regarding
the subject matter hereof.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of December 7, 2017.
Signature: /s/ Joel S. Marcus Joel S. Marcus